Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 110.29 | N/A |
| PEG Ratio (TTM) | -1.14 | N/A |
| P/S Ratio (TTM) | 1.97 | N/A |
| P/B Ratio (TTM) | 0.97 | N/A |
| P/FCF Ratio (TTM) | -270.64 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.41 | N/A |
| Price to 5YR AVG FCF Ratio | 6.84 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.08% | N/A |
| ROE (TTM) | 0.97% | N/A |
| Net Profit Margin (TTM) | 1.71% | N/A |
| ROIC 5YR AVG | 7.30% | N/A |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 44.89% | 25.80% | -0.73% |
| Revenue | 0.00% | 4.17% | -0.75% |
| Net Income | -16.54% | 21.90% | -2.17% |
| Cash Flow | -185.57% | -19.18% | 39.00% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 22.38 | N/A |
| Quick Ratio (TTM) | 22.38 | N/A |
| D/E Ratio (TTM) | 1.07 | N/A |
| Interest Coverage (TTM) | 0.68 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.61 | N/A |
| LTL to 5YR AVG FCF | 7.73 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.27% | N/A |